title: Impact of cilostazol on intimal proliferation after directional coronary atherectomy.
abstract: Cilostazol, a novel platelet aggregation inhibitor, inhibits intimal proliferation in animal models. We randomly assigned 41 patients with lesions suitable for directional coronary atherectomy to the cilostazol group (200 mg/day) or the aspirin (250 mg/day) group. Medication was started before directional coronary atherectomy and was continued to a 6-month follow-up. Serial quantitative coronary angiography and intravascular ultrasound study were performed. Baseline characteristics were not different between the two groups. However, the minimal lumen diameter at follow-up was larger (2.33 +/- 0.60 mm vs 1.81 +/- 0.68 mm, p = 0.016) and the percent diameter stenosis (24.5% +/- 16.6% vs 40.9% +/- 21.0%, p = 0.010) was smaller in the cilostazol group. The change in vessel area was not different, but the percent plaque area at follow-up was smaller in the cilostazol group (55.7% +/- 11.2% vs 64.5% +/- 14.5%, p = 0.044). The restenosis rate was significantly lower in the cilostazol group (0% vs 26%, p = 0.020). We conclude that cilostazol appears to have an inhibitory effect on intimal proliferation after directional coronary atherectomy and may reduce restenosis.
authors.affiliation: Department of Cardiology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka-city, Japan.
authors.forename: E
authors.initials: E
authors.lastname: Tsuchikane
authors.forename: O
authors.initials: O
authors.lastname: Katoh
authors.forename: S
authors.initials: S
authors.lastname: Sumitsuji
authors.forename: A
authors.initials: A
authors.lastname: Fukuhara
authors.forename: M
authors.initials: M
authors.lastname: Funamoto
authors.forename: S
authors.initials: S
authors.lastname: Otsuji
authors.forename: H
authors.initials: H
authors.lastname: Tateyama
authors.forename: N
authors.initials: N
authors.lastname: Awata
authors.forename: T
authors.initials: T
authors.lastname: Kobayashi
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D001241:Aspirin / Q000494:pharmacology; D017225:Atherectomy, Coronary; D002455:Cell Division / Q000187:drug effects; D000077407:Cilostazol; D017023:Coronary Angiography; D003327:Coronary Disease / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D013777:Tetrazoles / Q000494:pharmacology*; D017539:Tunica Intima / Q000187:drug effects*; D018084:Ultrasonography, Interventional
chemical_list: D010975:Platelet Aggregation Inhibitors; D013777:Tetrazoles; D000077407:Cilostazol; D001241:Aspirin